Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Not Applicable

Completed

• Conditions: Overweight
• Interventions: Dietary Supplement: LMT1-48; Dietary Supplement: Placebo

• Registration Number: NCT03759743
• Lead Sponsor: Medy-Tox

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-04
• Study First Submitted: 2018-11-14
• Study First Submitted QC: 2018-11-28
• Study First Posted: 2018-11-30
• Primary Completion: 2019-08-17
• Study Completion: 2020-01-07
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-27
• Last Update Posted: 2020-07-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• Age between 19 and 70 years
• Overweight (25 kg/m2 ≤ body mass index (BMI) < 30 kg/m2)

Exclusion Criteria

• Pregnancy or breast-feeding
• Unstable body weight (body weight change > 10% within 3 months before screening)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Probiotics	LMT1-48	-
Placebo	Placebo	-

Primary Outcome Measures

Name	Time	Method
change from baseline fat percentage at 12 week	at baseline and 12-week follow-up	the body composition of the subjects was measured via dual-energy X-ray absorptiometry (DEXA) to determine

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam-si, Korea, Republic of